New CPT Code Announced to Report Novel Coronavirus Test

New CPT Code Announced to Report Novel Coronavirus Test

The American Medical Association (AMA) today announced that the CPT Editorial Panel approved a new addition to the Current Procedural Terminology (CPT) code set that will help streamline data-driven resource and allocation planning in the battle against the novel coronavirus (SARS-CoV-2) as the number of confirmed COVID-19 cases continues to rise in the United States.

“In the face of the COVID-19 pandemic, the CPT Editorial Panel has expedited approval of a unique CPT code to report laboratory testing services that diagnose the presence of the novel coronavirus,” said AMA President Patrice A. Harris, MD, MA. “The new CPT code assigned to the test for the novel coronavirus provides analytical advantages for tracking, allocating and optimizing resources as testing ramps up in the United States.”

The new Category I CPT code and long descriptor are:

  • 87635 Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe technique

The code is effective immediately for use as the industry standard for reporting of tests for the novel coronavirus. In addition to the long descriptor, CPT code 87635 has short and medium descriptors that can be accessed on the AMA website.

The CPT Editorial Panel, the independent body convened by the AMA with sole authority to manage revisions to the CPT code set, expedited the code development process for the novel coronavirus test. Development, review and approval of the new CPT code involved broad input from practicing physicians, the Centers for Disease Control and Prevention (CDC) and other experts.

Leave a comment

2 Comments

  1. Is there a different CPT Code for the RT-CV19-IgM/IgG Rapid Test? I am only finding CPT 87635 which is what we are using for the SARS-COV2 COVID -19 AMP PRB.

    1. did anyone find out anything about CPT codes for IgG and IgM COVID?

Send a Comment

Your email address will not be published. Required fields are marked *